Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00722254 · ClinicalTrials.gov registry record

Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder

A clinical trial, sponsored by University of Utah.

Terminated
Registry status
15
Enrollment target

NCT00722254 is a clinical trial that was terminated before completion, run by University of Utah. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00722254 was terminated before completion, sponsored by University of Utah.

TERMINATED
Registry status
15 participants
Enrollment target

Study Summary

To determine the prevalence of myelofibrosis in patients with primary pulmonary hypertension, and to discover if the fibrosis in these patients is primary (AMM) or secondary.

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2006-06
Est. Completion 2009-02

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT00722254

The ClinicalTrials.gov registry entry for NCT00722254 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00722254 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00722254 about?

NCT00722254 is a clinical study titled "Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder". To determine the prevalence of myelofibrosis in patients with primary pulmonary hypertension, and to discover if the fibrosis in these patients is primary (AMM) or secondary.

What is the current status of trial NCT00722254?

This trial is currently terminated. The enrollment target is 15 participants. The study started on 2006-06. Estimated completion is 2009-02.

Who is sponsoring clinical trial NCT00722254?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.